Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating armodafinil as adjunctive therapy for major depressive episodes in adults with Bipolar I disorder; results were posted after study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• NUVIGIL (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Depression | Phase 3 | Status: COMPLETED | Results posted: 2015-01-26